Chemical Industry

Bayer Schering Pharma AG

May 05, 2015

Site Classification	Key Data
Site Owner Bayer AG, Leverkursen Site Operator Bayer Schering Pharma AG Full Service (Plug & Play) Yes Fenced/Open Site Fenced R&D Support Yes	Total Site Area 18 hectares (44 acres) Total Free Area 2 hectares (5 acres) Number of Permanent Staff approx. 1.250 Number of Companies On-Site 5

Key Benefits for Investors

Infrastructure
- Standard utilities + purified water for pharmaceutical use, waste water treatment plant, especially suited for active ingredient waste water
- Centralized off-gas incineration unit
- Ammonia coolant system; cGMP- and DIN ISO 14001-compliant infrastructures (incl. high rack warehouse)
Raw Materials On-Site
Several solvents (e.g. acetone, caustic soda, ethanol, hydrochloric acid, isopropanol, methanol, toluene) for pharmaceutical use in centralized tank farm.
Services/Utilities
- Standard services (site security, occupational health and safety)
- cGMP-compliant services (i.e. training, documentation, auditing, maintenance and engineering)
- Support for start-up companies possible
R&D
Pilot plant for biotech processes and production capabilities for microbial and mammalian cell culture derived products, incl. lab and bench scale plants.

Target Investors

Producers of pharmaceutical chemicals and active (pharmaceutical) ingredients including fine chemicals, starting from biological or chemical sources – preferably small to medium-sized chemical, biological or technically orientated companies – which would benefit from the given “pharmaceutical environment”.